
INVO Fertility, Inc.
INVO Fertility, Inc. (IVF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ivf · stock forecast · 1 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$20.00
Consensus
$20.00
+1438.5% upside
Low
$20.00
Median: $20 · Last Close: $1.30
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Short-term predictions are paused during the ±3-day earnings window to avoid unreliable signals.
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IVF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-01-23 | Maxim Group | Upgrade ↑ | Hold→Buy |
Wall Street analysts have recently issued updated ratings on INVO Fertility, Inc. (IVF) stock. Of the recent 1 rating actions, 1 were upgrades and 0 were downgrades. 1 analysts currently cover IVF.
Analyst Recommendation Trends
IVF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$10M
↓ 59.9% YoY
Revenue Next Year
$16M
↑ 58.0% YoY
EPS This Year
$-2.90
EPS Next Year
$-1.00
↓ 65.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast IVF EPS of $-2.90 for the current fiscal year, based on estimates from 1 analysts. The IVF revenue forecast is $10M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IVF stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IVF price target is $20.00 (+1438.5% upside), with an analyst consensus of Buy.
INVO Fertility, Inc. trades on NASDAQ under the ticker IVF. The IVF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
IVF forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month IVF price target is $20.00, with a high forecast of $20.00 and a low of $20.00. The median price target is shown in the chart above when available. This implies +1438.5% potential upside from the current price of $1.30.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.